Luke Chen

I was diagnosed with G6PD deficiency as an infant when I experienced severe jaundice. Growing up, I learned to navigate a world full of hidden triggers—certain medications, foods like fava beans, and even some household chemicals could potentially cause dangerous hemolytic episodes.

My mother and sister also carry the G6PD gene, making this truly a family matter. This personal experience drove me to create G6PD.ai, the world's first AI-powered safety checker for G6PD patients. But I knew that managing triggers wasn't enough—I wanted to understand the science deeply enough to contribute to finding a cure.

My approach combines computational biology with emerging gene editing technologies. By studying G6PD protein structures through AlphaFold and exploring CRISPR-Cas9 therapeutic strategies, I'm working to bridge the gap between structural biology and clinical intervention.

This website documents my research journey and serves as a resource for others in the G6PD community. I believe that open science and collaboration are key to accelerating breakthroughs in rare disease research.